Search PubMed⌕ Search

PubMed · 15180115

Evaluating technology for acquisition.

Abstract

Cancer care consumes approximately 8% to 9% of all healthcare spending. The use of technology plays a key role in cancer, with both diagnostic and treatment implications, and technology is a large driver of healthcare spending. Understanding the role of technology and its integration in care may contribute to appropriate selection and utilization of technology, better decision making as to priorities in acquisition, and clinical cost efficiency.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Pat Stanfill Edens, Donna Weber. Evaluating technology for acquisition.. https://pubmed.ncbi.nlm.nih.gov/15180115/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Returns, not burns: how to ensure successful health IT investments.

With many types of financial investments, the hospital financial community has long-established, and relatively straightforward, practices for projecting and measuring returns. Not so with health IT investments, however, where returns can be difficult to identify and quantify and even harder to track. Yet the success of such an investment depends on measuring the returns--whether they be tangible or intangible, short-term or long-term--because effectively tracking returns is the only way to be sure of achieving them.

Capital Expenditures↗

Cancer care. Dagnostics. The waiting game.

Diagnostic services are improving thanks to massive investment in new equipment. Progress is hampered by a shortage of radiologists and radiographers. Changes to job designs, to the way patients are referred, and to cancer screening services are key to meeting diagnosis targets.

Capital Expenditures↗